ACNP Update on Annual Meeting Location Decision-Making

Click here to read the ACNP Statement!

Effects of MDMA and LSD co-administration

Neuropsychopharmacology Editor's Choice

Volume 48, Issue 13 (December 2023)

How COVID-19 Affects the Brain, Maura Boldrini, M.D., Ph.D.

Click here to watch the video sponsored by the Scientific Communications Committee

Choosing appropriate language to reduce the stigma around mental illness and substance use disorders

NPP Commentary by Nora Volkow, Joshua Gordon, and George Koob

Calcitonin Receptors as a Target for Opioid Use Disorder

Neuropsychopharmacology Editor's Choice

Volume 48, Issue 13 (December 2023)

Binge Drinking and Tolerance to Alcohol Cues

Neuropsychopharmacology Editor's Choice

Volume 48, Issue 13 (December 2023)

62nd Annual Meeting

Dec 3-6, 2023

Tampa, Florida
More Annual Meeting Info

Deadlines

e-Poster Upload

November 27, 2023

CME Deadline

January 12, 2024

Digital Library Resources

Go to the Digital Library

Neuro News

How the brain ages

A study of more than 100,000 brains provides "growth charts" for the brain over the lifespan. (Article - Nature News)

Read More

Twitter

ACNP Follow 4,858 8,787

The American College of Neuropsychopharmacology (ACNP) is the nation's premier professional society in brain, behavior, and psychopharmacology research.

ACNPorg
Load More...
Registration

Registration for the 62nd Annual Meeting is now open! It will be presented in hybrid format, both in person and virtually.
Program

The Annual Meeting Program is available and will be updated as meeting information confirms.

Travel Awards

ACNP annually selects distinguished young scientists to be a part of an outstanding scientific program in clinical and basic research. Application submissions are now closed.

ACNP is a non-profit, professional society dedicated to advancing the scientific understanding of and facilitating communication about disorders of the brain and behavior in order to advance their prevention and treatment.